Kawasaki disease: diagnosis, management, and long-term implications

Area of Science:

• Pediatric Rheumatology
• Cardiovascular Pathology
• Immunology

Background:

• Kawasaki disease (KD) is a leading cause of acquired pediatric cardiovascular disease in the US.
• Despite advances, coronary artery abnormalities persist in some children.
• The etiology of KD remains unknown, impacting long-term health outcomes.

Purpose of the Study:

• To review the current understanding of Kawasaki disease etiology and pathophysiology.
• To discuss contemporary management strategies and their impact on cardiovascular sequelae.
• To highlight recent diagnostic and follow-up recommendations for KD.

Main Methods:

• Literature review of Kawasaki disease research.
• Analysis of clinical therapies and their efficacy.
• Examination of pathophysiological mechanisms including cytokine elaboration.
• Review of updated diagnostic and follow-up guidelines.

Main Results:

• Kawasaki disease involves intense cytokine and vasoactive mediator release, affecting vascular integrity.
• Intravenous immune globulin and aspirin are primary treatments; steroids remain controversial.
• Severe cases may necessitate coronary reperfusion or surgery.
• KD can predict early-onset adult coronary artery disease.

Conclusions:

• Kawasaki disease requires ongoing research into its etiology and long-term cardiovascular impact.
• Current management strategies aim to mitigate coronary artery abnormalities.
• Updated guidelines offer a stratified approach to diagnosis and follow-up for KD patients.